Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (891-900 of 1,158) with videos related to

Pageof 116
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneMark J Canet, Matthew D Merrell, Bryan G Harder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
[<sup>18</sup>F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung DiseasesJoanna C Porter, Balaji Ganeshan, Thida Win, et al.
Annals of the Rheumatic Diseases|April 30, 2026
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trialAnna-Maria Hoffmann-Vold, Shervin Assassi, Vincent Cottin, et al.
The European Respiratory Journal|October 3, 2020
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosisToby M Maher, Ulrich Costabel, Marilyn K Glassberg, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
Insights Into Imaging|February 7, 2014
Non-contrast CT at comparable dose to an abdominal radiograph in patients with acute renal colic; impact of iterative reconstruction on image quality and diagnostic performanceP D McLaughlin, K P Murphy, S A Hayes, et al.
Human Pathology|November 21, 1998
Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure?M J Roth, W Guo-Qing, K J Lewin, et al.
Chest|May 15, 2023
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung DiseaseKatherine J Myall, Alex G West, Jennifer L Martinovic, et al.
The European Respiratory Journal|July 7, 2017
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2012
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trialsThida Win, Tryphon Lambrou, Brian F Hutton, et al.
Pageof 116

Showing results (891-900 of 1,158) with videos related to

Sort By:
Pageof 116
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneMark J Canet, Matthew D Merrell, Bryan G Harder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2024
[<sup>18</sup>F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung DiseasesJoanna C Porter, Balaji Ganeshan, Thida Win, et al.
Annals of the Rheumatic Diseases|April 30, 2026
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trialAnna-Maria Hoffmann-Vold, Shervin Assassi, Vincent Cottin, et al.
The European Respiratory Journal|October 3, 2020
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosisToby M Maher, Ulrich Costabel, Marilyn K Glassberg, et al.
The Lancet. Respiratory Medicine|July 22, 2019
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.
Insights Into Imaging|February 7, 2014
Non-contrast CT at comparable dose to an abdominal radiograph in patients with acute renal colic; impact of iterative reconstruction on image quality and diagnostic performanceP D McLaughlin, K P Murphy, S A Hayes, et al.
Human Pathology|November 21, 1998
Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure?M J Roth, W Guo-Qing, K J Lewin, et al.
Chest|May 15, 2023
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung DiseaseKatherine J Myall, Alex G West, Jennifer L Martinovic, et al.
The European Respiratory Journal|July 7, 2017
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 20, 2012
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trialsThida Win, Tryphon Lambrou, Brian F Hutton, et al.
Pageof 116